TY - JOUR
T1 - Role of heavy sweating for ST-segment elevation myocardial infarction
T2 - analysis of the China Acute Myocardial Infarction registry
AU - on behalf of the China Acute Myocardial Infarction Registry Study Group
AU - Wu, Chao
AU - Zhang, Zilong
AU - Su, Shuhong
AU - Xu, Haiyan
AU - Song, Lei
AU - Wu, Yongjian
AU - Qiao, Shubin
AU - Wang, Yang
AU - Li, Wei
AU - Tang, Yida
AU - Gao, Xiaojin
AU - Yang, Jingang
AU - Yang, Yuejin
AU - Wang, Dong
AU - Wang, Tiansong
AU - Li, Bin
AU - Luobu, Gesang
AU - Xu, Jinlong
AU - Liu, Xiaoming
AU - Li, Yi
AU - Guo, Tao
AU - Mai, Haiyuan
AU - Zhang, Gaoxing
AU - Wu, Wei
AU - Chen, Jiyan
AU - Jiang, Xianwen
AU - Zhao, Chengyuan
AU - Yuan, Zhengqiang
AU - Yang, Tianhe
AU - Liu, Qishou
AU - Ye, Junming
AU - Cheng, Xiaoshu
AU - Lai, Meisheng
AU - Zhu, Hai
AU - Li, Lang
AU - Xiao, Yuquan
AU - Zhong, Dechao
AU - zhang, Haibo
AU - Zhou, Chonglun
AU - Zeng, Jianping
AU - Zhou, Shenhua
AU - Zhang, Laxi
AU - Wan, Shuping
AU - peng, Shuixian
AU - wang, Daowen
AU - Chen, Kaihong
AU - chen, Ping
AU - Wang, Yan
AU - Chen, Lianglong
AU - Yuan, Zuyi
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Background: Sweating in individuals with suspected cardiac chest pain indicates a greater risk of experiencing ST-segment elevation myocardial infarction (STEMI). Nevertheless, the relationship between sweating and clinical outcomes remains inadequately explored. Methods: From 2013 through 2016, 19112 patients with STEMI enrolled in the China Acute Myocardial Infarction registry. Heavy sweating was evaluated on admission and usually judged by dampen clothing. Thrombolysis in Myocardial Infarction (TIMI) flow and ST-segment resolution (STR) were used to evaluated the myocardial reperfusion after primary percutaneous myocardial infarction (PCI). The primary outcome was all-cause death during hospitalization and at 24 months. Results: Thirteen thousand, four hundred twenty-two patients (70.2%) presented heavy sweating, that was associated with age < 65 years, severe chest pain, current smoking status, and heart rates < 100 bpm on admission. Heavy sweating group was more likely to achieve primary PCI (44.7% vs 32.9%) but shown similar rates of post-PCI TIMI 3 flow (95.5% vs 94.1%) and STR ≥ 50% (79.8% vs 78.2%). After multivariable analysis, heavy sweating was significantly linked to lower in-hospital (5.9% vs 8.6%, odds ratio [OR]: 0.81, 95% confidence interval [CI]: 0.72–0.92) and 24-month mortality (11.0% vs 17.2%, hazard ratio [HR]: 0.75, 95% CI: 0.69–0.82). Even among patients undergoing primary PCI who achieved successful myocardial reperfusion, this short- (2.5% vs 4.2%, OR: 0.60, 95% CI: 0.45–0.80) and long-term (5.9% vs 8.7%, HR: 0.68, 95% CI: 0.56–0.83) prognostic significance remained robust. Conclusions: For STEMI, the presence of heavy sweating was associated with lower mortality regardless of successful primary PCI, which highlight the potential for early risk stratification based on the sweating presentation. Trial registration: https//www.clinicaltrials.gov. Unique identifier: NCT01874691. Registered 11/06/2013.
AB - Background: Sweating in individuals with suspected cardiac chest pain indicates a greater risk of experiencing ST-segment elevation myocardial infarction (STEMI). Nevertheless, the relationship between sweating and clinical outcomes remains inadequately explored. Methods: From 2013 through 2016, 19112 patients with STEMI enrolled in the China Acute Myocardial Infarction registry. Heavy sweating was evaluated on admission and usually judged by dampen clothing. Thrombolysis in Myocardial Infarction (TIMI) flow and ST-segment resolution (STR) were used to evaluated the myocardial reperfusion after primary percutaneous myocardial infarction (PCI). The primary outcome was all-cause death during hospitalization and at 24 months. Results: Thirteen thousand, four hundred twenty-two patients (70.2%) presented heavy sweating, that was associated with age < 65 years, severe chest pain, current smoking status, and heart rates < 100 bpm on admission. Heavy sweating group was more likely to achieve primary PCI (44.7% vs 32.9%) but shown similar rates of post-PCI TIMI 3 flow (95.5% vs 94.1%) and STR ≥ 50% (79.8% vs 78.2%). After multivariable analysis, heavy sweating was significantly linked to lower in-hospital (5.9% vs 8.6%, odds ratio [OR]: 0.81, 95% confidence interval [CI]: 0.72–0.92) and 24-month mortality (11.0% vs 17.2%, hazard ratio [HR]: 0.75, 95% CI: 0.69–0.82). Even among patients undergoing primary PCI who achieved successful myocardial reperfusion, this short- (2.5% vs 4.2%, OR: 0.60, 95% CI: 0.45–0.80) and long-term (5.9% vs 8.7%, HR: 0.68, 95% CI: 0.56–0.83) prognostic significance remained robust. Conclusions: For STEMI, the presence of heavy sweating was associated with lower mortality regardless of successful primary PCI, which highlight the potential for early risk stratification based on the sweating presentation. Trial registration: https//www.clinicaltrials.gov. Unique identifier: NCT01874691. Registered 11/06/2013.
KW - Myocardial infarction
KW - Outcome
KW - Sweating
KW - Symptom
UR - https://www.scopus.com/pages/publications/105005955334
U2 - 10.1186/s12872-025-04840-3
DO - 10.1186/s12872-025-04840-3
M3 - 文章
C2 - 40394465
AN - SCOPUS:105005955334
SN - 1471-2261
VL - 25
JO - BMC Cardiovascular Disorders
JF - BMC Cardiovascular Disorders
IS - 1
M1 - 385
ER -